- Home
- Labeler Index
- Eli Lilly Italia Spa
- 54568-766
- NDC Crossover: 54568-766 Insulin Glargine
NDC Crossover 54568-766 Insulin Glargine
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Insulin Glargine
The Similar Products in this help users find alternative medications and related products based on key similarities in their regulatory status, product name, active ingredients, dosage form, and administration route.
Explore similar products to 54568-766 – Insulin Glargine, drug for further processing. This list includes other cross-matching products that share:
- The same product name: Insulin Glargine
- OR Generic name: Insulin Glargine
- AND the same Administration Route:
- OR Dosage Form: injection, solution
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
0002-7715 | Basaglar KwikPen | Insulin Glargine | Injection, Solution | Subcutaneous | Eli Lilly And Company | Human Prescription Drug |
0002-8214 | Basaglar Tempo Pen | Insulin Glargine | Injection, Solution | Subcutaneous | Eli Lilly And Company | Human Prescription Drug |
0024-5869 | Toujeo | Insulin Glargine | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | Human Prescription Drug |
0024-5871 | Toujeo Max | Insulin Glargine | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | Human Prescription Drug |
0088-2219 | Lantus Solostar | Insulin Glargine | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | Human Prescription Drug |
0088-2220 | Lantus | Insulin Glargine | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | Human Prescription Drug |
0088-5020 | Lantus Solostar | Insulin Glargine | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | Human Prescription Drug |
0088-5021 | Lantus | Insulin Glargine | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | Human Prescription Drug |
0955-1728 | Insulin Glargine Solostar | Insulin Glargine | Injection, Solution | Subcutaneous | Winthrop U.s. | Human Prescription Drug |
0955-1729 | Insulin Glargine | Insulin Glargine | Injection, Solution | Subcutaneous | Winthrop U.s. | Human Prescription Drug |
0955-2900 | Insulin Glargine U-300 Max | Insulin Glargine | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | Human Prescription Drug |
0955-3900 | Insulin Glargine U-300 | Insulin Glargine | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | Human Prescription Drug |
50090-0876 | Lantus | Insulin Glargine | Injection, Solution | Subcutaneous | A-s Medication Solutions | Human Prescription Drug |
50090-1398 | Lantus Solostar | Insulin Glargine | Injection, Solution | Subcutaneous | A-s Medication Solutions | Human Prescription Drug |
50090-2193 | Toujeo | Insulin Glargine | Injection, Solution | Subcutaneous | A-s Medication Solutions | Human Prescription Drug |
50090-4068 | Lantus Solostar | Insulin Glargine | Injection, Solution | Subcutaneous | A-s Medication Solutions | Human Prescription Drug |
50090-4177 | Toujeo Max | Insulin Glargine | Injection, Solution | Subcutaneous | A-s Medication Solutions | Human Prescription Drug |
50090-6178 | Insulin Glargine Solostar | Insulin Glargine | Injection, Solution | Subcutaneous | A-s Medication Solutions | Human Prescription Drug |
50090-6184 | Insulin Glargine | Insulin Glargine | Injection, Solution | Subcutaneous | A-s Medication Solutions | Human Prescription Drug |